why choose us

First received: December 05, 2023

Clinical Trial: Ilofotase Alfa for Prevention of Renal Damage After Cardiac Surgery

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Open Heart Surgery

Study Type: INTERVENTIONAL


Official Title: Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ilofotase Alfa in Patients at Risk for Renal Damage Following Open Heart Surgery

Brief Summary: The aim of this clinical trial is to evaluate the efficacy and safety of two intravenous administrations of ilofotase alfa in patients at risk for renal damage following open heart surgery.

Read more